The Cost-Effectiveness and Budget Impact of Introducing Indacaterol into the Colombian Health System-Reference-Cited by-同舟云学术

The Cost-Effectiveness and Budget Impact of Introducing Indacaterol into the Colombian Health System

Published:2012-12 Issue:2 Volume:1 Page:165-171
ISSN:2212-1099
Container-title:Value in Health Regional Issues
language:en
Short-container-title:Value in Health Regional Issues

Author:

Guillermo Ariza Juan,Thuresson Per-Olof,Machnicki Gerardo,Mungapen Laura,Kraemer Matthias,Asukai Yumi,Fernando Giraldo Luis

Publisher

Elsevier BV

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Reference30 articles.

1. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study);Caballero;Chest,2008

2. Departamento Administrativo Nacional de Estadística. Proyecciones nacionales y departamentales de población 2005-2020. 〈http://www.dane.gov.co/7E6820E3-5620-4692-8068-414B56D829F2/FinalDownload/DownloadId-D83E1F8F60C9B32826937968C9D17ECE/7E6820E3-5620-4692-8068-414B56D829F2/files/investigaciones/poblacion/proyepobla06_20/8Tablasvida1985_2020.pdf〉. [Accessed August 28, 2012].

3. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. Available from: http://www.goldcopd.org/.

4. Acosta N, Peñaloza RE, Rodríguez-García J. Carga de Enfermedad Colombia 2005: Resultados Alcanzados. Cendex 2008; Available from: http://www.cendex.org.co/GPES/informes/PresentacionCarga_Informe.pdf

5. Cost-utility analysis of indacaterol in Germany: a once-daily maintenance bronchodilator for patients with COPD;Price;Respir Med,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Health Economics Simulation Models of Chronic Obstructive Pulmonary Disease;Value in Health;2017-01

2. Beneficios clínicos y económicos de la terapia con bomba de insulina integrada a sistema de monitoreo continuo de glucosa en los pacientes diabéticos tipo 1 en Colombia;Endocrinología y Nutrición;2016-11

3. Clinical and economic benefits of integrated pump/CGM technology therapy in patients with type 1 diabetes in Colombia;Endocrinología y Nutrición (English Edition);2016-11

4. Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat® fixed-dose combination for chronic obstructive pulmonary disease patients in Italy;Therapeutic Advances in Respiratory Disease;2016-07-31

5. Budget impact analysis of medicines: updated systematic review and implications;Expert Review of Pharmacoeconomics & Outcomes Research;2016-03-03